CAU
VTRS icon

Caxton Associates (UK)’s Viatris VTRS Stock Holding History

Caxton Associates (UK)’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06M Sell
255,423
-213,789
-46% -$3.31M 0.08% 107
2026
Q1 		$6.34M Sell
469,212
-51,320
-10% -$718K 0.14% 46
2025
Q4 		$6.48M Buy
520,532
+6,943
+1% +$74.9K 0.13% 51
2025
Q3 		$5.08M Buy
513,589
+248,432
+94% +$2.42M 0.12% 69
2025
Q2 		$2.37M Buy
265,157
+251,459
+1,836% +$2.13M 0.06% 159
2025
Q1 		$119K Buy
+13,698
New +$144K ﹤0.01% 733

Other funds holding VTRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caxton Associates (UK)'s VTRS Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Viatris (VTRS) stake by 46% in Q2 2026, selling an estimated $3.31M and leaving 255,423 shares worth $4.06M. The position accounts for 0.08% of the portfolio, ranked #107.

Caxton Associates (UK) first reported a position in VTRS in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.48M in Q4 2025. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Caxton Associates (UK) held 255,423 shares of Viatris worth $4.06M as of Q2 2026.
  • Caxton Associates (UK) sold 213,789 Viatris shares in Q2 2026, an estimated $3.31M.
  • Viatris made up 0.08% of Caxton Associates (UK)'s portfolio in Q2 2026, its #107 holding.
  • Caxton Associates (UK) first reported a position in Viatris in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s Viatris position peaked at $6.48M in Q4 2025.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.